Komori
Share Issuance and Disposal4591RIBOMIC Inc.Pharmaceuticals

Notice Regarding the Designation of a Suspension Period for the Exercise of the 19th Series Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Clause)

The allottee was notified that exercise of the entire remaining amount of the 19th Stock Acquisition Rights would be suspended from 15 June to 18 September 2026.

Worth reading
55In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
9160000
Shares (number of shares remaining unexercised)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Designation of suspension of exercise of the 19th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause)

Intended allottee
EVO FUND
Terms of the stock acquisition rights
Exercise price
With an exercise price adjustment clause; amount and adjustment floor are Not disclosed
Number of Stock Acquisition Rights
Total issued: Not disclosed; remaining unexercised: 91,600 rights (9,160,000 shares)
Most recent equity financing
8 August 2025: Issuance of the 19th Stock Acquisition Rights (see the materials released on 23 July 2025 for details)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDesignation of suspension of exercise of the 19th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause)
Intended allotteeEVO FUND
Exercise priceWith an exercise price adjustment clause; amount and adjustment floor are Not disclosed
Number of Stock Acquisition RightsTotal issued: Not disclosed; remaining unexercised: 91,600 rights (9,160,000 shares)
Most recent equity financing8 August 2025: Issuance of the 19th Stock Acquisition Rights (see the materials released on 23 July 2025 for details)
Items this document does not state (23)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company stated that it may suspend or resume exercise while assessing stock price trends.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Designation of a Suspension Period for the Exercise of the 19th Series Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Clause) | RIBOMIC Inc. (4591) timely disclosure | Komori